Xu, W. (2026) “CRISPR/Cas9-Mediated PD-1 Engineered T Cells: New Strategy to Block Tumor Immune Escape”, International Journal of Biology and Life Sciences, 16(1), pp. 252–255. doi:10.54097/edfqwy74.